Text Size

Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye

Daull P., Feraille L., Barabino S., Cimbolini N., Antonelli S., Mauro V., Garrigue J.-S.

  • 2016
  • Experimental Eye Research
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Preclinical development

  • Affiliations

    SANTEN SAS, Novagali Innovation Center, 1, rue Pierre Fontaine, Bâtiment Genavenir IV, Evry Cedex, F-91458, France; Iris Pharma, Les Nertières, Allée Hector PintusLa Gaude F-06610, France; Clinica Oculistica, Di.N.O.G.M.I., Azienda Ospedaliera Universitaria San Martino-IST, Genoa, Italy

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.

Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022